Metabolic and cardiovascular effects of early insulin glargin prescription: based on data from ORIGIN study
We discuss results of ORIGIN, a multicenter parallel groups study for efficiency assessment of insulin glargin against polyunsaturatedomega-3 fatty acids or placebo regarding cardiovascular and/or mortality risk reduction in patients with impaired fasting glycemia,impaired glucose tolerance or type...
Guardado en:
Autores principales: | Elena Valer'evna Biryukova, Alexander Sergeevich Ametov, Mikhail Borisovich Antsiferov, Alsu Gafurovna Zalevskaya, Galina Afanas'evna Mel'nichenko, Ashot Musaelovich Mkrtumyan, Marina Vladimirovna Shestakova |
---|---|
Formato: | article |
Lenguaje: | EN RU |
Publicado: |
Endocrinology Research Centre
2012
|
Materias: | |
Acceso en línea: | https://doaj.org/article/b7e6d26cdbee4110988b38b6e29a334f |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Insulin glargine: pharmacokinetic and pharmacodynamic basis of clinical effect
por: Vadim Valer'evich Klimontov, et al.
Publicado: (2014) -
Osobennosti sakharnogo diabeta v pozhilom vozraste i printsipy terapii
por: Ashot Musaelovich Mkrtumyan, et al.
Publicado: (2005) -
Ispol'zovanie inkretinov v lecheniisakharnogo diabeta 2 tipa - vcherashnyaya mechta,blizkaya k real'nosti segodnya
por: Ashot Musaelovich Mkrtumyan, et al.
Publicado: (2006) -
rDNA insulin glargine U300 – a critical appraisal
por: Wang F, et al.
Publicado: (2016) -
On the safety of insulin Glargine
por: Ivan Ivanovich Dedov, et al.
Publicado: (2009)